Inventor
WEINER HOWARD L
US38 patents
⚠️ This page may combine multiple inventors who share the name “WEINER HOWARD L”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AUTOIMMUNE INC
31 patentsUS5869093AFeb 9, 1999
Treatment of immune diseases by oral administration of autoantigens
AUTOIMMUNE INC137 citations99
US5733547AMar 31, 1998
Treatment of autoimmune arthritis by oral administration of type I or type III collagen
AUTOIMMUNE INC112 citations99
US5869054AFeb 9, 1999
Treatment of multiple sclerosis by oral administration of autoantigens
AUTOIMMUNE INC122 citations98
US5763396AJun 9, 1998
Method of treating or preventing type 1 diabetes by oral administration of insulin
AUTOIMMUNE INC208 citations98
US5645820AJul 8, 1997
Treatment of autoimmune diseases by aerosol administration of autoantigens
AUTOIMMUNE INC112 citations98
US5641474AJun 24, 1997
Prevention of autoimmune diseases by aerosol administration of autoantigens
AUTOIMMUNE INC109 citations98
US5641473AJun 24, 1997
Treatment of autoimmune diseases by aerosol administration of autoantigens
AUTOIMMUNE INC104 citations98
US5571499ANov 5, 1996
Treatment of autoimmune diseases by aerosol administration of autoantigens
AUTOIMMUNE INC110 citations98
US5399347AMar 21, 1995
Method of treating rheumatoid arthritis with type II collagen
AUTOIMMUNE INC109 citations97
US6077509AJun 20, 2000
Peptide fragments of myelin basic protein
AUTOIMMUNE INC47 citations96
US5858980AJan 12, 1999
Peptide fragments of myelin basic protein
AUTOIMMUNE INC90 citations96
US5849298ADec 15, 1998
Treatment of multiple sclerosis by oral administration of bovine myelin
AUTOIMMUNE INC70 citations96
US5571500ANov 5, 1996
Treatment of autoimmune diseases through administration by inhalation of autoantigens
AUTOIMMUNE INC92 citations96
US6703361B2Mar 9, 2004
Method of treating or preventing Type 1 diabetes by oral administration of insulin
AUTOIMMUNE INC63 citations95
US5858968AJan 12, 1999
Method of treating or preventing type 1 diabetes by oral administration of insulin
AUTOIMMUNE INC63 citations95
US5643868AJul 1, 1997
Method of treating or preventing type 1 diabetes by oral administration of insulin
AUTOIMMUNE INC38 citations95
US6645504B1Nov 11, 2003
Bystander suppression of type I diabetes by oral administration of glucagon
AUTOIMMUNE INC58 citations94
US6036957AMar 14, 2000
Suppression of T-cell proliferation using peptide fragments of myelin basic protein
AUTOIMMUNE INC64 citations94
US6039947AMar 21, 2000
Peptides derived from immunodominant epitopes of myelin basic protein
AUTOIMMUNE INC21 citations93
US6019971AFeb 1, 2000
Treatment of autoimmune arthritis by oral administration of collagen
AUTOIMMUNE INC19 citations93
US5858364AJan 12, 1999
Pharmaceutical dosage form for treatment of multiple sclerosis
AUTOIMMUNE INC24 citations93
US5856446AJan 5, 1999
Method of treating rheumatoid arthritis with low dose type II collagen
AUTOIMMUNE INC29 citations92
US5843886ADec 1, 1998
Method of treating or preventing Type 1 diabetes by oral administration of insulin
AUTOIMMUNE INC18 citations92
US5783188AJul 21, 1998
Method of treating rheumatoid arthritis with type collagen peptide fragments containing repeating sequences
AUTOIMMUNE INC17 citations92
US5720955AFeb 24, 1998
Method of treating rheumatoid arthritis with soluble collagen
AUTOIMMUNE INC28 citations92
US5843445ADec 1, 1998
Method of treating rheumatoid arthritis with type II collagen
AUTOIMMUNE INC19 citations91
US5593698AJan 14, 1997
Suppression of proliferative response and induction of tolerance with polymorphic class II MHC allopeptides
AUTOIMMUNE INC33 citations91
US5935577AAug 10, 1999
Treatment of autoimmune disease using tolerization in combination with methotrexate
AUTOIMMUNE INC33 citations89
US5961977AOct 5, 1999
Method of treating or preventing autoimmune uveoretinitis in mammals
AUTOIMMUNE INC14 citations71
US5788968AAug 4, 1998
Methods and compositions for suppressing allograft rejection in mammals
AUTOIMMUNE INC8 citations70
US5681556AOct 28, 1997
Method and compositions for suppressing allograft rejection in mammals
AUTOIMMUNE INC2 citations59
BRIGHAM & WOMENS HOSPITAL INC
3 patentsUS10017567B2Jul 10, 2018
Treatment of cancer with anti-LAP monoclonal antibodies
BRIGHAM & WOMENS HOSPITAL INC23 citations89
US10287347B2May 14, 2019
Treatment of cancer with anti-lap monoclonal antibodies
BRIGHAM & WOMENS HOSPITAL INC1 citations68
US11407823B2Aug 9, 2022
Treatment of cancer with anti-LAP monoclonal antibodies
BRIGHAM & WOMENS HOSPITAL INC0 citations58